Top

Published in:

01-07-2020 | Splenectomy | Letter to Editor

Successful Artery Embolization in a Patient with Autoimmune Lymphoproliferative Syndrome Associated with Splenic Rupture

Authors: Kensaku Kohrogi, Masahiro Migita, Tadashi Anan, Takeshi Sugahara, Kazuhiko Yoshimoto, Hirokazu Kanegane, Kimitoshi Nakamura

Published in: Journal of Clinical Immunology | Issue 5/2020

Excerpt

To the Editor, …

Available only for authorised users

Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):35–40. https://doi.org/10.1182/blood-2010-04-280347.CrossRef

Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, et al. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood. 2016;127(1):17–28. https://doi.org/10.1182/blood-2015-07-657981.CrossRefPubMedPubMedCentral

Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, de Somer L, et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118(18):4798–807. https://doi.org/10.1182/blood-2011-04-347641.CrossRefPubMed

Aubrey-Bassler FK, Sowers N. 613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review. BMC Emerg Med. 2012;12. https://doi.org/10.1186/1471-227X-12-11.

Kis B, Mills M, Smith J, Choi J, Sagatys E, Komrokji R, et al. Partial splenic artery embolization in 35 cancer patients: results of a single institution retrospective study. J Vasc Interv Radiol. 2019;31(4):584–91. https://doi.org/10.1016/j.jvir.2019.05.031.CrossRefPubMed

Foley PT, Kavnoudias H, Cameron PU, Czarnecki C, Paul E, Lyon SM. Proximal versus distal splenic artery embolisation for blunt splenic trauma: what is the impact on splenic immune function? Cardiovasc Intervent Radiol. 2015;38(5):1143–51. https://doi.org/10.1007/s00270-015-1162-8.CrossRefPubMed

Haas JP, Grunke M, Frank C, Kolowos W, Dirnecker D, Leipold G, et al. Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation. Cell Death Differ. 1998;5(9):751–7. https://doi.org/10.1038/sj.cdd.4400426.CrossRefPubMed

Peters AMJ, Kohfink B, Martin H, Griesinger F, Wörmann B, Gahr M, et al. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin’s disease. Exp Hematol. 1999;27(5):868–74. https://doi.org/10.1016/S0301-472X(99)00033-8.CrossRefPubMed

Title: Successful Artery Embolization in a Patient with Autoimmune Lymphoproliferative Syndrome Associated with Splenic Rupture
Authors: Kensaku Kohrogi
Masahiro Migita
Tadashi Anan
Takeshi Sugahara
Kazuhiko Yoshimoto
Hirokazu Kanegane
Kimitoshi Nakamura
Publication date: 01-07-2020
Publisher: Springer US
Keywords: Splenectomy
Splenectomy
Spleen Rupture
Lymphadenopathy
Published in: Journal of Clinical Immunology / Issue 5/2020
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-020-00809-3

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Successful Artery Embolization in a Patient with Autoimmune Lymphoproliferative Syndrome Associated with Splenic Rupture

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2020

Correction to: A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

The Konya Declaration for Patients with Primary Immunodeficiencies

A Systematic Review and Meta-regression Analysis on the Impact of Increasing IgG Trough Level on Infection Rates in Primary Immunodeficiency Patients on Intravenous IgG Therapy

Haploinsufficiency of A20 Due to Novel Mutations in TNFAIP3

Anti-GM-CSF Autoantibodies and Cryptococcus neoformans var. grubii CNS Vasculitis

The Association of Fetal Thymus Size with Subsequent T Cell Counts in 22q11.2 Deletion Syndrome

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page